Importantly, it is still not clear whether sporadic and familial cases, or even the different mutations with converging proteopathies (e.g., GRN or C9orf72), share the same pathophysiological processes, which can ultimately impact the body-fluid biochemical profiles [13,14,15,16,17]. The gene discussed is GRN; the disease is proteostasis deficiencies.